Fast relief for seasonal and year-round allergies. Prescription antihistamines, nasal steroids, and montelukast — delivered to your pharmacy same day.

Board-Certified HIPAA-Compliant Same-Day Available DE · MD · WA

Book a Same-Day Visit →

What Is Allergic Rhinitis?

Allergic rhinitis is an IgE-mediated inflammatory condition of the nasal mucosa triggered by exposure to specific allergens such as pollen, dust mites, pet dander, mold spores, and cockroach allergens. It affects an estimated 10–30% of the global population, making it one of the most prevalent chronic conditions in the United States. According to the American College of Allergy, Asthma and Immunology (ACAAI), approximately 60 million Americans are affected annually, with significant economic burden from missed workdays, impaired sleep, and reduced quality of life. Allergic rhinitis is classified as seasonal (triggered by outdoor allergens such as tree, grass, and weed pollens), perennial (triggered year-round by indoor allergens), or mixed.

The underlying immunopathology involves sensitization — initial allergen exposure stimulates B-lymphocytes to produce IgE antibodies, which bind to mast cells and basophils in the nasal mucosa. Upon subsequent allergen exposure, cross-linking of IgE triggers mast cell degranulation and release of histamine, leukotrienes, prostaglandins, and cytokines. This early-phase reaction occurs within minutes and produces sneezing, rhinorrhea, and itching. A late-phase reaction 4–8 hours later, driven by eosinophil infiltration, causes nasal congestion and mucosal hyperresponsiveness. Allergic rhinitis is strongly associated with asthma (the "unified airway" concept), with 40% of patients having comorbid asthma, and vice versa. It is also associated with allergic conjunctivitis, chronic sinusitis, and obstructive sleep apnea.

Telehealth is an excellent fit for allergic rhinitis evaluation and management. At Innocre Telehealth, our board-certified provider, evaluates patients in Delaware, Maryland, and Washington using a thorough history of symptom patterns, triggers, living environment, and prior treatment response. Most patients with clear allergic symptoms do not require in-person allergy testing before initiating pharmacotherapy. your provider prescribes evidence-based first-line treatments in accordance with Joint Task Force on Practice Parameters (JTFPP) and ACAAI guidelines, with same-day e-prescriptions sent to your pharmacy.

Common Symptoms

How Innocre Treats Allergies Online

Per ACAAI and JTFPP guidelines, intranasal corticosteroids (INCs) are the single most effective pharmacologic treatment for allergic rhinitis and are considered first-line therapy for moderate-to-severe or persistent symptoms. your board-certified provider prescribes INCs including fluticasone propionate (Flonase), mometasone furoate (Nasonex), and budesonide — agents with excellent local anti-inflammatory efficacy and minimal systemic bioavailability. For patients with predominantly histamine-driven symptoms (sneezing, rhinorrhea, itch), second-generation oral antihistamines are preferred due to their favorable side-effect profiles: cetirizine (Zyrtec, 10 mg daily), loratadine (Claritin, 10 mg daily), and fexofenadine (Allegra, 180 mg daily) are all highly effective and non-sedating. First-generation antihistamines (diphenhydramine, chlorpheniramine) are used cautiously due to sedation and anticholinergic effects.

Montelukast (Singulair), a leukotriene receptor antagonist, is an additional option particularly useful for patients with comorbid asthma or exercise-induced bronchoconstriction alongside allergic rhinitis. However, the FDA has issued a black-box warning regarding neuropsychiatric adverse effects including mood changes and suicidal ideation — your provider discusses this risk-benefit profile with each patient individually before prescribing. For patients with significant eye symptoms, prescription or OTC antihistamine/mast-cell stabilizer eye drops (e.g., olopatadine) may be added. Nasal saline irrigation is a highly evidence-based adjunctive measure that reduces allergen load and improves mucosal clearance.

In patients with allergic rhinitis uncontrolled on optimal pharmacotherapy, referral to an allergist for allergen immunotherapy (allergy shots or sublingual tablets/drops) should be considered — your provider can facilitate this referral for patients in Delaware, Maryland, and Washington. Avoidance strategies are also discussed: keeping windows closed during high pollen counts, using HEPA filters, frequent hand-washing after outdoor exposure, and showering before bed to reduce nocturnal allergen exposure. For patients with undiagnosed atopic conditions or suspected food allergies, appropriate referrals and workup are arranged.